In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease.

Pharmaceutics · 2025 · PMC12196245 · PMID 40574039

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Interestingly, although we observed a trend towards silencing using these two siRNAs with Lipofectamine TM RNAiMAX, this did not reach statistical significance ( Figure 9 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.